STOCK TITAN

PARK HA BIOLOGICAL TECHNOLOGY Stock Price, News & Analysis

BYAH NASDAQ

Company Description

Park Ha Biological Technology Co., Ltd. (Nasdaq: BYAH) is a company whose business activities, according to available information, center on skincare and cosmetic products marketed under the Park Ha brand in China. The company is involved in developing its own private skincare label and distributing these products through direct sales and franchise-related promotion channels. Its brand positioning focuses on providing solutions for problematic skin, and its operating subsidiaries handle both product development and customer-facing services in physical locations.

Business focus and activities

Park Ha Biological Technology Co., Ltd. is engaged in the development of proprietary beauty and skincare products under the Park Ha name. Based on the available description, the company’s operating subsidiaries provide skincare and cosmetic products under this brand in China and are responsible for creating and refining the company’s own beauty formulations.

The company also conducts direct skincare product sales and participates in franchise alliances promotions. This indicates that, in addition to selling products directly, it works with franchise partners to promote its brand and offerings. Its physical stores provide complimentary after-sales beauty services, which are positioned as a way to support customers who use Park Ha products and to reinforce the brand’s focus on problematic skin.

Brand positioning

The Park Ha brand is described as focusing on solutions for problematic skin. Within this framework, the company emphasizes proprietary beauty products and after-sales beauty services offered in physical stores. These services are characterized as complimentary and are intended to support customers following their purchase of Park Ha skincare or cosmetic products.

Trading symbol and Nasdaq listing

Park Ha Biological Technology Co., Ltd. has announced that its ordinary shares trade on Nasdaq. The company stated that it would change its ticker symbol from PHH to BYAH, and that, effective on October 28, 2025, its ordinary shares would trade on Nasdaq under the new symbol BYAH. The company has indicated that its ordinary shares will continue to be listed on Nasdaq in connection with this symbol change and that the CUSIP will remain unchanged.

According to the company’s announcement, the purpose of the ticker symbol change is to prevent potential confusion with a previously delisted company that used the same symbol. The company also stated that it expects the change of ticker symbol to support the development of its long-term brand influence and brand value.

Corporate structure and operations

Available information notes that Park Ha Biological Technology Co., Ltd. operates through its operating subsidiaries, which develop proprietary beauty products and offer complimentary after-sales beauty services in physical stores. These subsidiaries are responsible for providing skincare and cosmetic products under the Park Ha brand in China.

The company’s activities, as described, combine product development, brand-focused marketing, and in-person services. Direct skincare product sales and franchise alliances promotions are mentioned as key channels through which the Park Ha brand is promoted and its products are brought to customers.

Investor considerations

From an investor information standpoint, Park Ha Biological Technology Co., Ltd. presents itself as a skincare and cosmetic products company with a specific focus on problematic skin and a brand-based strategy in China. Its Nasdaq listing under the symbol BYAH and the formal announcement of its ticker symbol change from PHH to BYAH are key structural details disclosed by the company.

Investors reviewing Park Ha Biological Technology Co., Ltd. can consider the company’s emphasis on proprietary product development, its use of physical stores to provide complimentary after-sales beauty services, and its reliance on both direct sales and franchise alliances promotions as described in available materials. The company has also publicly communicated that the ticker symbol change is intended to avoid confusion with a delisted company that previously used the same symbol and to support its brand-building efforts.

Stock Performance

$—
0.00%
0.00
Last updated:
-91.32%
Performance 1 year

Financial Highlights

$2.4M
Revenue (TTM)
$479K
Net Income (TTM)
$960K
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in PARK HA BIOLOGICAL TECHNOLOGY (BYAH) currently stands at 563.2 thousand shares, up 100.0% from the previous reporting period, representing 43.9% of the float. Over the past 12 months, short interest has increased by 386.5%. This high level of short interest suggests significant bearish sentiment among traders.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for PARK HA BIOLOGICAL TECHNOLOGY (BYAH) currently stands at 1.0 days, down 49.5% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.0 days.

Frequently Asked Questions

What is the current stock price of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The current stock price of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is $1.62 as of March 4, 2026.

What is the market cap of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The market cap of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is approximately 3.5M. Learn more about what market capitalization means .

What is the revenue (TTM) of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) stock?

The trailing twelve months (TTM) revenue of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is $2.4M.

What is the net income of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The trailing twelve months (TTM) net income of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is $479K.

What is the earnings per share (EPS) of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The diluted earnings per share (EPS) of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is $0.02 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The operating cash flow of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is $960K. Learn about cash flow.

What is the profit margin of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The net profit margin of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is 20.1%. Learn about profit margins.

What is the operating margin of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The operating profit margin of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is 33.3%. Learn about operating margins.

What is the gross margin of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The gross profit margin of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is 91.8%. Learn about gross margins.

What is the current ratio of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The current ratio of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is 1.87, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The gross profit of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is $2.2M on a trailing twelve months (TTM) basis.

What is the operating income of PARK HA BIOLOGICAL TECHNOLOGY (BYAH)?

The operating income of PARK HA BIOLOGICAL TECHNOLOGY (BYAH) is $794K. Learn about operating income.

What does Park Ha Biological Technology Co., Ltd. do?

Park Ha Biological Technology Co., Ltd. is involved in developing its private skincare label and providing skincare and cosmetic products under the Park Ha brand in China. Its activities include direct skincare product sales, franchise alliances promotions, and complimentary after-sales beauty services in physical stores.

What is the focus of the Park Ha brand?

The Park Ha brand focuses on providing solutions for problematic skin. According to available information, the company’s operating subsidiaries develop proprietary beauty products and offer after-sales beauty services that support customers using Park Ha skincare and cosmetic products.

Where does Park Ha Biological Technology Co., Ltd. offer its products?

Available information states that the operating subsidiaries of Park Ha Biological Technology Co., Ltd. provide skincare and cosmetic products under the Park Ha brand in China. These activities include product development, sales, and after-sales beauty services in physical stores.

How does Park Ha Biological Technology Co., Ltd. sell and promote its products?

Park Ha Biological Technology Co., Ltd. engages in direct skincare product sales and franchise alliances promotions. This means it sells products directly and also works with franchise partners to promote the Park Ha brand and its skincare and cosmetic offerings.

What kind of services are offered in Park Ha physical stores?

According to available information, the operating subsidiaries of Park Ha Biological Technology Co., Ltd. offer complimentary after-sales beauty services in their physical stores. These services are intended to support customers after they purchase Park Ha skincare and cosmetic products.

On which exchange does Park Ha Biological Technology Co., Ltd. trade and under what symbol?

Park Ha Biological Technology Co., Ltd. has announced that its ordinary shares are listed on Nasdaq. The company stated that it would change its ticker symbol from PHH to BYAH, and that its ordinary shares would trade on Nasdaq under the new symbol BYAH effective October 28, 2025.

Why did Park Ha Biological Technology Co., Ltd. change its ticker symbol to BYAH?

The company announced that it would change its ticker symbol from PHH to BYAH to prevent potential confusion with a delisted company that previously used the same symbol. It also stated that the change is expected to have a positive impact on building its long-term brand influence and enhancing its brand value.

Does the ticker symbol change to BYAH affect existing shareholders?

According to the company’s announcement, no action is required by existing shareholders in connection with the ticker symbol change from PHH to BYAH. The company also indicated that its ordinary shares will continue to be listed on Nasdaq and that the CUSIP will remain unchanged.